动脉瘤性蛛网膜下腔出血围手术期再出血的影响
该研究基于长崎SAH注册研究4933例动脉瘤性SAH患者,回顾性分析围手术期再出血的预测因素及其对临床结局的影响。结果显示术前、术中和术后再出血率分别为7.2%、11.2%和2.4%,各期再出血均显著影响临床结局,前交通动脉瘤术中再出血风险较高,血管内栓塞可能有助于预防术中再出血。
要点
- 术前再出血与年龄、多发动脉瘤、动脉瘤大小和心脏病显著相关。
- 术中再出血与动脉瘤位置(前交通动脉)、家族史、术前再出血和夹闭/栓塞显著相关。
- 各期再出血均显著贡献于SAH后的临床结局。
核心结论
- 动脉瘤性SAH后再出血在术前、术中和术后各期具有特定特征,且均影响临床结局。
- 前交通动脉瘤术中再出血风险较高,血管内栓塞可能是预防术中再出血的良好技术选择,但需完全闭塞动脉瘤。
研究设计与样本
- 回顾性分析长崎SAH注册研究中2000年起4933例动脉瘤性SAH患者的数据,采用多因素logistic回归分析再出血的危险因素和结局。
主要发现
- 术前再出血发生率为7.2%,与年龄(p=0.01)、多发动脉瘤(p<0.01)、动脉瘤大小(p<0.0001)和心脏病(p=0.03)显著相关。
- 术中再出血发生率为11.2%,与动脉瘤位置(前交通动脉)、家族史(p=0.02)、术前再出血(p<0.01)和夹闭/栓塞(p<0.0001)显著相关。
- 交互分析显示夹闭在前交通动脉瘤显著影响术中再出血(OR 4.00;95%CI 1.82-8.80;p<0.001)。
- 术后再出血发生率为2.4%,与夹闭/栓塞(p<0.0001)和术中再出血(p<0.01)显著相关。
- 所有观察期的再出血均显著贡献于SAH后的临床结局。
临床怎么用
- 对于具有术前再出血危险因素(如年龄、多发动脉瘤、动脉瘤大小、心脏病)的患者,应加强急性期管理。
- 前交通动脉瘤患者术中再出血风险较高,血管内栓塞可能有助于预防术中再出血,但需确保动脉瘤完全闭塞。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Aneurysm rebleeding is a major cause of death and morbidity in patients with aneurysmal subarachnoid hemorrhage (SAH). Recognizing the predictors of rebleeding might help to identify patients who will benefit from acute management. This study was performed to investigate the predictors of aneurysm rebleeding and their impact on clinical outcomes in the preoperative, intraoperative, and postoperative periods. METHODS: The incidence of rebleeding, demographic data, and clinical data from 4933 patients with aneurysmal SAH beginning in the year 2000 were retrospectively analyzed in the Nagasaki SAH Registry Study. The authors performed multiple logistic regression analyses to identify the risk factors contributing to rebleeding and outcome after SAH. RESULTS: Preoperative rebleeding occurred in 7.2% of patients. Patient age (p = 0.01), multiple aneurysms (p < 0.01), aneurysm size (p < 0.0001), and heart disease (p = 0.03) were significantly associated with preoperative rebleeding. Conversely, intraoperative rebleeding occurred in 11.2% of patients. Aneurysm location (anterior communicating artery [ACoA]), family history (p = 0.02), preoperative rebleeding (p < 0.01), and clipping/coiling (p < 0.0001) were significantly associated with intraoperative rebleeding. Interaction analysis showed that clipping significantly affected intraoperative rebleeding at the ACoA (OR 4.00; 95% CI 1.82-8.80; p < 0.001). Postoperative rebleeding occurred in 2.4% of patients. Coiling/clipping (p < 0.0001) and intraoperative rebleeding (p < 0.01) were significantly associated with postoperative rebleeding. Rebleeding in all time periods examined significantly contributed to the clinical outcome after SAH. CONCLUSIONS: Aneurysm rebleeding after SAH has specific characteristics in the preoperative, intraoperative, and postoperative periods, and all of these characteristics contribute to the clinical outcome. The ACoA has a higher risk of intraoperative rebleeding, and endovascular coiling could be a good candidate in terms of techniques for preventing intraoperative rebleeding, although complete aneurysm obliteration should be accomplished.
引用
- Horie N, Sato S, Kaminogo M, et al. Impact of perioperative aneurysm rebleeding after subarachnoid hemorrhage. J Neurosurg. 2019. PMID: 31518984. doi:10.3171/2019.6.JNS19704
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。